Physician profile
Michael R Go
NPI 1225297377
$2,778.92
in general payments reported to CMS, 2019-2025
6 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $147 · 2022: $160 · 2023: $238 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,125 · Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,125.00 |
| Food and Beverage | $237.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,233.95 | 2021-2025 | Abre |
| W. L. Gore & Associates, INC. | $134.71 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Boston Scientific Corporation | $131.57 | 2022 | |
| Smith+Nephew, INC. | $131.46 | 2022-2023 | Stravix Pl |
| Tepha INC | $109.23 | 2019 | |
| Penumbra, INC. | $38.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.